Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma.
Hu D, Ansari D, Pawłowski K, Zhou Q, Sasor A, Welinder C, Kristl T, Bauden M, Rezeli M, Jiang Y, Marko-Varga G, Andersson R.
Hu D, et al.
Oncotarget. 2018 Jan 3;9(11):9789-9807. doi: 10.18632/oncotarget.23929. eCollection 2018 Feb 9.
Oncotarget. 2018.
PMID: 29515771
Free PMC article.